• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Androgens for genitourinary and vasomotor symptoms associated with menopause.用于治疗与绝经相关的泌尿生殖系统症状和血管舒缩症状的雄激素。
Cochrane Database Syst Rev. 2025 Jun 17;6(6):CD016052. doi: 10.1002/14651858.CD016052.
2
Phytoestrogens for menopausal vasomotor symptoms.植物雌激素用于治疗更年期血管舒缩症状。
Cochrane Database Syst Rev. 2013 Dec 10;2013(12):CD001395. doi: 10.1002/14651858.CD001395.pub4.
3
Exercise for vasomotor menopausal symptoms.针对血管舒缩性更年期症状的运动
Cochrane Database Syst Rev. 2014 Nov 28;2014(11):CD006108. doi: 10.1002/14651858.CD006108.pub4.
4
Short-term and long-term effects of tibolone in postmenopausal women.替勃龙对绝经后女性的短期和长期影响。
Cochrane Database Syst Rev. 2016 Oct 12;10(10):CD008536. doi: 10.1002/14651858.CD008536.pub3.
5
Long-term hormone therapy for perimenopausal and postmenopausal women.围绝经期和绝经后女性的长期激素治疗
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.
6
Dehydroepiandrosterone for women in the peri- or postmenopausal phase.绝经前后阶段女性使用脱氢表雄酮。
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD011066. doi: 10.1002/14651858.CD011066.pub2.
7
Bioidentical hormones for women with vasomotor symptoms.用于有血管舒缩症状女性的生物同源激素。
Cochrane Database Syst Rev. 2016 Aug 1;2016(8):CD010407. doi: 10.1002/14651858.CD010407.pub2.
8
Chinese herbal medicine for menopausal symptoms.用于缓解更年期症状的中草药
Cochrane Database Syst Rev. 2016 Mar 15;3(3):CD009023. doi: 10.1002/14651858.CD009023.pub2.
9
Exercise for vasomotor menopausal symptoms.针对血管舒缩性更年期症状的锻炼
Cochrane Database Syst Rev. 2007 Oct 17(4):CD006108. doi: 10.1002/14651858.CD006108.pub2.
10
Exercise for vasomotor menopausal symptoms.针对血管舒缩性更年期症状的锻炼。
Cochrane Database Syst Rev. 2011 May 11(5):CD006108. doi: 10.1002/14651858.CD006108.pub3.

本文引用的文献

1
The Impact of Testosterone Therapy on Cardiovascular Risk Among Postmenopausal Women.睾酮治疗对绝经后女性心血管风险的影响
J Endocr Soc. 2023 Oct 25;8(1):bvad132. doi: 10.1210/jendso/bvad132. eCollection 2023 Dec 1.
2
Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?重新思考更年期激素治疗：针对谁、什么、何时以及多长时间？
Circulation. 2023 Feb 14;147(7):597-610. doi: 10.1161/CIRCULATIONAHA.122.061559. Epub 2023 Feb 13.
3
Management of Menopausal Symptoms: A Review.绝经症状管理：综述。
JAMA. 2023 Feb 7;329(5):405-420. doi: 10.1001/jama.2022.24140.
4
Medical Treatment of Female Sexual Dysfunction.女性性功能障碍的治疗。
Urol Clin North Am. 2022 May;49(2):299-307. doi: 10.1016/j.ucl.2022.02.001.
5
Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden.全球绝经相关血管舒缩症状女性的横断面调查：患病率和生活质量负担。
Menopause. 2021 May 24;28(8):875-882. doi: 10.1097/GME.0000000000001793.
6
A core outcome set for genitourinary symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative.与绝经相关的泌尿生殖系统症状的核心结局集：COMMA（绝经核心结局）全球倡议。
Menopause. 2021 May 10;28(8):859-866. doi: 10.1097/GME.0000000000001788.
7
A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative.一项与绝经相关血管舒缩症状的核心结局集：COMMA（绝经核心结局）全球倡议。
Menopause. 2021 Apr 26;28(8):852-858. doi: 10.1097/GME.0000000000001787.
8
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.国际女性性健康研究学会关于女性性欲减退障碍使用系统性睾酮的临床实践指南。
J Sex Med. 2021 May;18(5):849-867. doi: 10.1016/j.jsxm.2020.10.009. Epub 2021 Apr 1.
9
Genitourinary syndrome of menopause: a systematic review on prevalence and treatment.绝经后泌尿生殖系统综合征：患病率和治疗的系统评价。
Menopause. 2021 Mar 15;28(6):706-716. doi: 10.1097/GME.0000000000001752.
10
The Menopause Transition: Signs, Symptoms, and Management Options.更年期过渡：迹象、症状和管理选择。
J Clin Endocrinol Metab. 2021 Jan 1;106(1):1-15. doi: 10.1210/clinem/dgaa764.

用于治疗与绝经相关的泌尿生殖系统症状和血管舒缩症状的雄激素。

Androgens for genitourinary and vasomotor symptoms associated with menopause.

作者信息

Lara Lucia A, Cartagena-Ramos Denisse, Cantelli Debora, Dias Carla M F, Armstrong Sarah, Jordan Vanessa, Fuentealba-Torres Miguel

机构信息

Department of Obstetrics and Gynecology, Medical School of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil.

Faculty of Nursing, Universidad Andres Bello, Santiago de Chile, Chile.

出版信息

Cochrane Database Syst Rev. 2025 Jun 17;6(6):CD016052. doi: 10.1002/14651858.CD016052.

DOI:10.1002/14651858.CD016052
PMID:40525531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12172151/
Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of androgens compared to placebo or no intervention, or another active treatment for genitourinary and vasomotor symptoms in perimenopausal or postmenopausal women.

摘要

这是一项Cochrane系统评价（干预措施）的方案。目标如下：评估与安慰剂、无干预措施或其他针对围绝经期或绝经后女性泌尿生殖系统及血管舒缩症状的积极治疗相比，雄激素的益处和危害。